Balloon septostomy is a percutaneous cardiac catheterisation technique in which a flexible balloon catheter is used to enlarge an existing interatrial communication or to create a new atrial septal defect. The procedure is most commonly performed in neonates and infants with congenital heart defects that result in critically reduced systemic or pulmonary blood flow, such as transposition of the great arteries (TGA) with an intact ventricular septum, hypoplastic left heart syndrome, or severe pulmonary hypertension.
Procedure
A catheter with an inflatable balloon at its tip is introduced into a central vein (usually the femoral or umbilical vein) and advanced under fluoroscopic and echocardiographic guidance to the right atrium. The balloon is positioned against the atrial septum, inflated, and then rapidly retracted (“balloon pull” or “Rashkind maneuver”) to tear the septal tissue, thereby creating or enlarging an atrial communication. In some variations, a static balloon is inflated and left in place to maintain patency, or a cutting balloon may be employed. The size of the defect can be modified by selecting an appropriate balloon diameter and by repeating the maneuver.
Indications
Balloon septostomy is indicated primarily as a palliative or bridge procedure to:
- Improve mixing of oxygenated and deoxygenated blood in cyanotic heart disease pending definitive surgical repair.
- Relieve left‑right shunt obstruction in conditions such as d‑transposition of the great arteries with intact ventricular septum.
- Reduce right‑to‑left shunt in severe pulmonary hypertension when temporary reduction of systemic desaturation is required.
- Provide atrial decompression in certain forms of single‑ventricle physiology.
Contraindications and Risks
Absolute contraindications include the presence of a large, restrictive atrial septal defect that would render the procedure unnecessary, and severe coagulopathy. Relative contraindications involve atrial thrombus, anomalous pulmonary venous return, or certain anatomical variations that increase the risk of cardiac perforation. Documented complications include:
- Cardiac arrhythmias (e.g., atrial flutter, ventricular tachycardia)
- Cardiac perforation or tamponade
- Embolisation of the balloon
- Creation of an excessively large atrial defect leading to volume overload
- Vascular injury at the access site
Outcomes and Follow‑up
Balloon septostomy typically yields rapid improvement in arterial oxygen saturation, often within minutes to hours after the procedure. The effect may be temporary, lasting from weeks to months, depending on the underlying pathology and the natural tendency of the septal tear to close. Patients are usually monitored in a neonatal intensive care setting, with serial echocardiographic assessments to evaluate defect size and hemodynamic impact.
Historical Context
The technique was first described by Dr. William Rashkind in 1966, who pioneered the “balloon atrial septostomy” for neonates with TGA. Since then, refinements such as the use of larger or cutting balloons, and adjunctive imaging modalities, have expanded its applicability.
Current Use
While surgical atrial septectomy remains an option, balloon septostomy is preferred when rapid, minimally invasive palliation is required. It continues to be a standard component of the therapeutic algorithm for selected congenital heart diseases worldwide.